Relmada Therapeutics, Inc.
DE ˙ DB ˙ US75955J4022
5,35 € ↓ -0,35 (-6,14%)
2026-06-03
AKTIENPREIS
SecurityDE:4E2 / Relmada Therapeutics, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in 4E2 / Relmada Therapeutics, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Relmada Therapeutics, Inc. (DE:4E2) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 18,611 shares of Relmada Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (4E2) in the form of stock options. The firm currently holds call options representing 60,500 of underlying shares valued at $421,080 USD and put options representing 26,200 of underlying shares valued at $182,352 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:4E2 / Relmada Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F RELMADA THERAPEUTICS COM 75955J402 0 -18,611 -100.00 0 -100.00
2026-02-11 2025-12-31 13F RELMADA THERAPEUTICS COM 75955J402 18,611 -34,471 -64.94 90 0.0001
2025-11-12 2025-09-30 13F RELMADA THERAPEUTICS COM 75955J402 53,082 50,655 2,087.14 0 0.0001
2025-08-05 2025-06-30 13F RELMADA THERAPEUTICS COM 75955J402 2,427 -2,055 -45.85 0 0.0000
2025-05-12 2025-03-31 13F RELMADA THERAPEUTICS COM 75955J402 4,482 4,482 0 0.0000
2025-02-11 2024-12-31 13F RELMADA THERAPEUTICS COM 75955J402 0 -12,506 -100.00 0 0.0000
2024-11-08 2024-09-30 13F RELMADA THERAPEUTICS COM 75955J402 12,506 -28,764 -69.70 0 0.0000
2024-07-25 2024-06-30 13F RELMADA THERAPEUTICS COM 75955J402 41,270 -5,443 -11.65 0 0.0001
2024-04-25 2024-03-31 13F RELMADA THERAPEUTICS COM 75955J402 46,713 -9,272 -16.56 0 0.0001
2024-02-02 2023-12-31 13F RELMADA THERAPEUTICS COM 75955J402 55,985 17,664 46.09 0 0.0001
2023-11-01 2023-09-30 13F RELMADA THERAPEUTICS COM 75955J402 38,321 -6,042 -13.62 0 0.0001
2023-08-04 2023-06-30 13F RELMADA THERAPEUTICS COM 75955J402 44,363 39,859 884.97 0 0.0001
2023-04-27 2023-03-31 13F RELMADA THERAPEUTICS COM 75955J402 4,504 4,504 0 0.0000
2022-05-02 2022-03-31 13F RELMADA THERAPEUTICS COM 75955J402 0 -9,143 -100.00 0 -100.00
2022-02-23 2021-12-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 9,143 5,057 123.76 205 49.64 0.0002
2022-02-04 2021-12-31 13F RELMADA THERAPEUTICS COM 75955J402 4,086 0 137 0.0001
2021-10-28 2021-09-30 13F RELMADA THERAPEUTICS COM 75955J402 4,086 200 5.15 137 10.48 0.0001
2021-08-12 2021-06-30 13F RELMADA THERAPEUTICS COM 75955J402 3,886 -4,357 -52.86 124 -57.24 0.0001
2021-04-26 2021-03-31 13F RELMADA THERAPEUTICS COM 75955J402 8,243 8,243 112.12 290 133.87 0.0005
2020-10-14 2020-09-30 13F RELMADA THERAPEUTICS COM 75955J402 0 -878 -100.00 0 -100.00
2020-07-13 2020-06-30 13F RELMADA THERAPEUTICS COM 75955J402 878 353 67.24 39 129.41 0.0001
2020-04-29 2020-03-31 13F RELMADA THERAPEUTICS COM 75955J402 525 -1,615 -75.47 17 -79.52 0.0000
2020-02-05 2019-12-31 13F RELMADA THERAPEUTICS COM 75955J402 2,140 2,140 83 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F RELMADA THERAPEUTICS CALL Call 60,500 89.66 421 173.38 n/a n/a n/a
2026-02-11 2025-12-31 13F RELMADA THERAPEUTICS CALL Call 31,900 10,533.33 154 n/a n/a n/a
2025-11-12 2025-09-30 13F RELMADA THERAPEUTICS CALL Call 300 0 n/a n/a n/a
2025-08-05 2025-06-30 13F RELMADA THERAPEUTICS CALL Call 0 -100.00 0 n/a n/a n/a
2025-05-12 2025-03-31 13F RELMADA THERAPEUTICS CALL Call 100 -99.89 0 n/a n/a n/a
2025-02-11 2024-12-31 13F RELMADA THERAPEUTICS CALL Call 91,400 153.19 0 n/a n/a n/a
2024-11-08 2024-09-30 13F RELMADA THERAPEUTICS CALL Call 36,100 464.06 0 n/a n/a n/a
2024-07-25 2024-06-30 13F RELMADA THERAPEUTICS CALL Call 6,400 -1.54 0 n/a n/a n/a
2024-04-25 2024-03-31 13F RELMADA THERAPEUTICS CALL Call 6,500 364.29 0 n/a n/a n/a
2024-02-02 2023-12-31 13F RELMADA THERAPEUTICS CALL Call 1,400 -82.28 0 n/a n/a n/a
2023-11-01 2023-09-30 13F RELMADA THERAPEUTICS CALL Call 7,900 464.29 0 n/a n/a n/a
2023-08-04 2023-06-30 13F RELMADA THERAPEUTICS CALL Call 1,400 -77.78 0 n/a n/a n/a
2023-04-27 2023-03-31 13F RELMADA THERAPEUTICS CALL Call 6,300 -96.10 0 n/a n/a n/a
2023-02-02 2022-12-31 13F RELMADA THERAPEUTICS CALL Call 161,600 35.80 1 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F RELMADA THERAPEUTICS CALL Call 119,000 -22.22 4,405 51.64 n/a n/a n/a
2022-08-03 2022-06-30 13F RELMADA THERAPEUTICS CALL Call 153,000 116.41 2,905 52.25 n/a n/a n/a
2022-05-02 2022-03-31 13F RELMADA THERAPEUTICS CALL Call 70,700 6,970.00 1,908 8,572.73 n/a n/a n/a
2022-02-23 2021-12-31 13F/A RELMADA THERAPEUTICS CALL Call 1,000 -90.38 22 -93.70 n/a n/a n/a
2022-02-04 2021-12-31 13F RELMADA THERAPEUTICS CALL Call 10,400 349 n/a n/a n/a
2021-10-28 2021-09-30 13F RELMADA THERAPEUTICS CALL Call 10,400 0.00 349 5.12 n/a n/a n/a
2021-08-12 2021-06-30 13F RELMADA THERAPEUTICS CALL Call 10,400 18,471.43 332 68.53 n/a n/a n/a
2021-04-26 2021-03-31 13F RELMADA THERAPEUTICS CALL Call 56 30.23 197 43.80 n/a n/a n/a
2021-02-02 2020-12-31 13F RELMADA THERAPEUTICS CALL Call 43 -59.81 137 -65.92 n/a n/a n/a
2020-10-14 2020-09-30 13F RELMADA THERAPEUTICS CALL Call 107 174.36 402 131.03 n/a n/a n/a
2020-07-13 2020-06-30 13F RELMADA THERAPEUTICS CALL Call 39 550.00 174 770.00 n/a n/a n/a
2020-04-29 2020-03-31 13F RELMADA THERAPEUTICS CALL Call 6 -53.85 20 -60.00 n/a n/a n/a
2020-02-05 2019-12-31 13F RELMADA THERAPEUTICS CALL Call 13 50 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F RELMADA THERAPEUTICS PUT Put 26,200 182 n/a n/a n/a
2025-05-12 2025-03-31 13F RELMADA THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2025-02-11 2024-12-31 13F RELMADA THERAPEUTICS PUT Put 1,400 -87.50 0 n/a n/a n/a
2024-11-08 2024-09-30 13F RELMADA THERAPEUTICS PUT Put 11,200 64.71 0 n/a n/a n/a
2024-07-25 2024-06-30 13F RELMADA THERAPEUTICS PUT Put 6,800 466.67 0 n/a n/a n/a
2024-04-25 2024-03-31 13F RELMADA THERAPEUTICS PUT Put 1,200 -97.72 0 n/a n/a n/a
2024-02-02 2023-12-31 13F RELMADA THERAPEUTICS PUT Put 52,600 9.13 0 n/a n/a n/a
2023-11-01 2023-09-30 13F RELMADA THERAPEUTICS PUT Put 48,200 -7.13 0 n/a n/a n/a
2023-08-04 2023-06-30 13F RELMADA THERAPEUTICS PUT Put 51,900 0 n/a n/a n/a
2023-04-27 2023-03-31 13F RELMADA THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F RELMADA THERAPEUTICS PUT Put 8,000 -94.03 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F RELMADA THERAPEUTICS PUT Put 134,000 -15.14 4,960 65.44 n/a n/a n/a
2022-08-03 2022-06-30 13F RELMADA THERAPEUTICS PUT Put 157,900 200.76 2,998 111.72 n/a n/a n/a
2022-05-02 2022-03-31 13F RELMADA THERAPEUTICS PUT Put 52,500 1,844.44 1,416 1,473.33 n/a n/a n/a
2022-02-04 2021-12-31 13F RELMADA THERAPEUTICS PUT Put 2,700 0.00 90 0.00 n/a n/a n/a
2021-10-28 2021-09-30 13F RELMADA THERAPEUTICS PUT Put 2,700 0.00 90 4.65 n/a n/a n/a
2021-08-12 2021-06-30 13F RELMADA THERAPEUTICS PUT Put 2,700 12,757.14 86 17.81 n/a n/a n/a
2021-04-26 2021-03-31 13F RELMADA THERAPEUTICS PUT Put 21 2,000.00 73 2,333.33 n/a n/a n/a
2021-02-02 2020-12-31 13F RELMADA THERAPEUTICS PUT Put 1 0.00 3 0.00 n/a n/a n/a
2020-10-14 2020-09-30 13F RELMADA THERAPEUTICS PUT Put 1 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.